<DOC>
	<DOCNO>NCT02261116</DOCNO>
	<brief_summary>Study assess potential different property telmisartan , due Vd , result strong `` beneficial '' effect AT1 blockade tissue ( e.g . aldosterone suppression renin increase ) plus strong AT2 stimulation compare candesartan</brief_summary>
	<brief_title>Study Assess Potential Different Properties Telmisartan Compared Candesartan Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>1 . Males , age 18 45 year . 2 . Absence relevant disease determine clinically deviation normal medical history , clinical laboratory determination , ECGs physical examination 3 . Systolic blood pressure ( SBP ) 100 140 mmHg systolic 85 mmHg diastolic ( left right arm ) heart rate ≥50 bpm 4 . Signed informed consent form 5 . No intake drug inbetween wait time ten time halflife 1 . Contraindications Ang II antagonist , know hypersensitivity , history angioedema , serious allergy , asthma , allergic skin rash , significant allergic rhinitis sensitivity drug 2 . History cardiovascular disease : clinically significant cardiovascular disease , supine diastolic blood pressure &gt; 86 mmHg systolic &gt; 141 mmHg measure standard sphygmomanometer heart rate ≤49 bpm 3 . Cerebrovascular disease : history stroke transitory ischemic attack ( TIAs ) history cerebral bleeding 4 . Renal disease : serum creatinine &gt; 1.5 mg/dL 5 . Gastrointestinal/Hepatic disease : Aspartate aminotransferase ( ASAT ) &gt; 40 U/l Alanine aminotransferase ( ALAT ) &gt; 40 U/L , serum bilirubin &gt; 2x upper limit normal , history malabsorption inability tolerate oral medication , history gastric duodenal ulcer , history significant gastrointestinal bleeding , history hepatitis within past year 6 . Any history alcohol drug abuse 7 . Use follow drug within 4 week study enrolment ( e.g . agent know induce drug metabolize enzyme ) : anabolic steroid corticoid , antiarrhythmic ( amiodarone , mexiletine , quinidine , propafenone ) , antibiotic ( chloramphenicol , tetracycline , sulfonamide , macrolides , cephalosporin , rifampicin , nalidixic acid ) , antiepileptic ( phenytoin , carbamazepine ) , antifungal ( e.g . griseofulvin ) , barbiturates , cimetidine , ethacrynic acid , fibrates , furosemide , haloperidol , lipid lower agent ( cholestyramine , hydroxymethylglutaryl , coenzyme A ( HMG CoA ) reductase inhibitor , dextrothyroxin ) , thyroid replacement therapy hormone thyrostatics ( thioureylenetype ) . The use nonsteroidal antiinflammatory drug ( NSAIDs ) discontinue 2 week prior study enrolment , one exception aspirin one ( 1 ) week prior study enrolment 8 . Participation investigational study , within 30 day prior enrolment 9 . Blood donation within previous 3 month 10 . The investigator might disqualify subject sound medical psychiatric reason</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>